Coronavirus impact: 29 April - surging profits and depression era declines
29/04/2020 · Alphabet (GOOGL) · Anpario PLC (ANP) · AstraZeneca (AZN) · Diaceutics PLC (DXRX) · EKF Diagnostics Holdings (EKF) · Fevertree Drinks PLC (FEVR) · Next (NXT) · Novacyt SA (NCYT) · NWF Group (NWF) · Persimmon (PSN)
AIM AIM Inheritance Tax potential Coronavirus Dividends UK US

One of the world’s largest companies issued impressive results but the outlook is significantly more challenging. There was also some financial guidance at last from a small diagnostic group whose Covid-19 tests are in strong demand. Our latest update reveals more winners and losers from the current crisis
Alphabet: fabulous quarter but..
Previous article Next article
DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREEDON'T MISS OUT ON OUR PREMIUM CONTENT
Become a champion investor for just £90 a year. Benefit from our high performing portfolios:
- Ultimate Stocks
- Income Boosters
- Mega Tends
- Bonkers Bargains
- Stonking Small Caps
- IHT qualifying selections
- ...and more
More on Alphabet
Ultimate Stocks Portfolio: Q1 2021 update
Having delivered a stunning performance in 2020, with the portfolio up 21%, the first quarter of…
Investing in electric vehicles and autonomous cars
The electric vehicle revolution is, as it were, gathering steam. The car in front will soon…
More on Anpario PLC
Coronavirus impact: 9 Sept - a day of concrete results
Plenty of results and plenty of positives from AIM companies to encourage
Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates
Cycling and video gaming are at opposite ends of the leisure spectrum, but both have benefited…
More on AstraZeneca
AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?
The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…
Coronavirus impact: 29 April - surging profits and depression era declines
One of the world’s largest companies issued impressive results but the outlook is significantly more challenging.…
More on Diaceutics PLC
An exciting play on the growing market of diagnostic data analytics
This company’s growing data lake of clinical testing data is helping big pharma improve patient testing,…
Coronavirus impact: 7 Sept - seaweed secures the dosh
News today from AIM includes the award of a significant grant to support investigation into the…
More on EKF Diagnostics Holdings
Why bother with an update!
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
Coronavirus impact: 9 Nov – a renewable energy day
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More on Fevertree Drinks PLC
Fevertree Drinks: growing fast in overseas markets
Shares tumble on the day of the results but the creator of delicious premium mixers looks…
Positive updates from AIM
Another big day of results and updates, with plenty to encourage investors in AIM
More on Next
Are Next and Burberry ready for the new retail normal?
Like many traditional retailers Next and Burberry have both been severely disrupted by lockdown measures caused by…
Coronavirus impact: 29 July - a lesson in excellent financial reporting
The latest report from Next provides a lesson in comprehensive reporting, if only others would follow their lead
More on Novacyt SA
Novacyt: shares take a beating
AIM’s top performer in 2020 has fallen back to earth after a disappointing trading update. Are…
Eclectic delights of AIM
Bonkers Bargains, new Covid tests, kettle controls, video game developers and franchised lettings – such are…
More on NWF Group
5 small cap dividend stocks for yield and growth
Is it possible to generate an attractive, growing income from small-cap shares? We have found some…
Coronavirus impact: 4 Aug – quality small caps going cheap
Several smaller companies featured here look cracking value, with the reassurance of plenty of cash
More on Persimmon
Do our Income Boosters need a housebuilder?
With UK housebuilders offering yields up to 8%, should we add one to our Income Boosters dividend…
Income Boosters: Does our dividend portfolio need a housebuilder?
Housebuilders have become income favourites in recent years, but our income portfolio doesn't have any exposure…